Copyright Reports & Markets. All rights reserved.

Global Latanoprost API Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Latanoprost API Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Latanoprost API by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Latanoprost API by Country/Region, 2017, 2022 & 2028
  • 2.2 Latanoprost API Segment by Type
    • 2.2.1 Liquid
    • 2.2.2 Powder
  • 2.3 Latanoprost API Sales by Type
    • 2.3.1 Global Latanoprost API Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Latanoprost API Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Latanoprost API Sale Price by Type (2017-2022)
  • 2.4 Latanoprost API Segment by Application
    • 2.4.1 Glaucoma
    • 2.4.2 High Eye Pressure
    • 2.4.3 Others
  • 2.5 Latanoprost API Sales by Application
    • 2.5.1 Global Latanoprost API Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Latanoprost API Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Latanoprost API Sale Price by Application (2017-2022)

3 Global Latanoprost API by Company

  • 3.1 Global Latanoprost API Breakdown Data by Company
    • 3.1.1 Global Latanoprost API Annual Sales by Company (2020-2022)
    • 3.1.2 Global Latanoprost API Sales Market Share by Company (2020-2022)
  • 3.2 Global Latanoprost API Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Latanoprost API Revenue by Company (2020-2022)
    • 3.2.2 Global Latanoprost API Revenue Market Share by Company (2020-2022)
  • 3.3 Global Latanoprost API Sale Price by Company
  • 3.4 Key Manufacturers Latanoprost API Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Latanoprost API Product Location Distribution
    • 3.4.2 Players Latanoprost API Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Latanoprost API by Geographic Region

  • 4.1 World Historic Latanoprost API Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Latanoprost API Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Latanoprost API Annual Revenue by Geographic Region
  • 4.2 World Historic Latanoprost API Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Latanoprost API Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Latanoprost API Annual Revenue by Country/Region
  • 4.3 Americas Latanoprost API Sales Growth
  • 4.4 APAC Latanoprost API Sales Growth
  • 4.5 Europe Latanoprost API Sales Growth
  • 4.6 Middle East & Africa Latanoprost API Sales Growth

5 Americas

  • 5.1 Americas Latanoprost API Sales by Country
    • 5.1.1 Americas Latanoprost API Sales by Country (2017-2022)
    • 5.1.2 Americas Latanoprost API Revenue by Country (2017-2022)
  • 5.2 Americas Latanoprost API Sales by Type
  • 5.3 Americas Latanoprost API Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Latanoprost API Sales by Region
    • 6.1.1 APAC Latanoprost API Sales by Region (2017-2022)
    • 6.1.2 APAC Latanoprost API Revenue by Region (2017-2022)
  • 6.2 APAC Latanoprost API Sales by Type
  • 6.3 APAC Latanoprost API Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Latanoprost API by Country
    • 7.1.1 Europe Latanoprost API Sales by Country (2017-2022)
    • 7.1.2 Europe Latanoprost API Revenue by Country (2017-2022)
  • 7.2 Europe Latanoprost API Sales by Type
  • 7.3 Europe Latanoprost API Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Latanoprost API by Country
    • 8.1.1 Middle East & Africa Latanoprost API Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Latanoprost API Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Latanoprost API Sales by Type
  • 8.3 Middle East & Africa Latanoprost API Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Latanoprost API
  • 10.3 Manufacturing Process Analysis of Latanoprost API
  • 10.4 Industry Chain Structure of Latanoprost API

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Latanoprost API Distributors
  • 11.3 Latanoprost API Customer

12 World Forecast Review for Latanoprost API by Geographic Region

  • 12.1 Global Latanoprost API Market Size Forecast by Region
    • 12.1.1 Global Latanoprost API Forecast by Region (2023-2028)
    • 12.1.2 Global Latanoprost API Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Latanoprost API Forecast by Type
  • 12.7 Global Latanoprost API Forecast by Application

13 Key Players Analysis

  • 13.1 Sanofi
    • 13.1.1 Sanofi Company Information
    • 13.1.2 Sanofi Latanoprost API Product Offered
    • 13.1.3 Sanofi Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Sanofi Main Business Overview
    • 13.1.5 Sanofi Latest Developments
  • 13.2 Cayman Pharma
    • 13.2.1 Cayman Pharma Company Information
    • 13.2.2 Cayman Pharma Latanoprost API Product Offered
    • 13.2.3 Cayman Pharma Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Cayman Pharma Main Business Overview
    • 13.2.5 Cayman Pharma Latest Developments
  • 13.3 Fleming Laboratories
    • 13.3.1 Fleming Laboratories Company Information
    • 13.3.2 Fleming Laboratories Latanoprost API Product Offered
    • 13.3.3 Fleming Laboratories Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Fleming Laboratories Main Business Overview
    • 13.3.5 Fleming Laboratories Latest Developments
  • 13.4 Euroapi
    • 13.4.1 Euroapi Company Information
    • 13.4.2 Euroapi Latanoprost API Product Offered
    • 13.4.3 Euroapi Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Euroapi Main Business Overview
    • 13.4.5 Euroapi Latest Developments
  • 13.5 Gentec Pharmaceutical Group
    • 13.5.1 Gentec Pharmaceutical Group Company Information
    • 13.5.2 Gentec Pharmaceutical Group Latanoprost API Product Offered
    • 13.5.3 Gentec Pharmaceutical Group Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Gentec Pharmaceutical Group Main Business Overview
    • 13.5.5 Gentec Pharmaceutical Group Latest Developments
  • 13.6 Century Pharmaceuticals
    • 13.6.1 Century Pharmaceuticals Company Information
    • 13.6.2 Century Pharmaceuticals Latanoprost API Product Offered
    • 13.6.3 Century Pharmaceuticals Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Century Pharmaceuticals Main Business Overview
    • 13.6.5 Century Pharmaceuticals Latest Developments
  • 13.7 Summit Pharmaceuticals
    • 13.7.1 Summit Pharmaceuticals Company Information
    • 13.7.2 Summit Pharmaceuticals Latanoprost API Product Offered
    • 13.7.3 Summit Pharmaceuticals Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Summit Pharmaceuticals Main Business Overview
    • 13.7.5 Summit Pharmaceuticals Latest Developments
  • 13.8 Aspen Biopharma
    • 13.8.1 Aspen Biopharma Company Information
    • 13.8.2 Aspen Biopharma Latanoprost API Product Offered
    • 13.8.3 Aspen Biopharma Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Aspen Biopharma Main Business Overview
    • 13.8.5 Aspen Biopharma Latest Developments
  • 13.9 Guangzhou Tosun Pharmaceutical
    • 13.9.1 Guangzhou Tosun Pharmaceutical Company Information
    • 13.9.2 Guangzhou Tosun Pharmaceutical Latanoprost API Product Offered
    • 13.9.3 Guangzhou Tosun Pharmaceutical Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Guangzhou Tosun Pharmaceutical Main Business Overview
    • 13.9.5 Guangzhou Tosun Pharmaceutical Latest Developments
  • 13.10 Berr Chemical
    • 13.10.1 Berr Chemical Company Information
    • 13.10.2 Berr Chemical Latanoprost API Product Offered
    • 13.10.3 Berr Chemical Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Berr Chemical Main Business Overview
    • 13.10.5 Berr Chemical Latest Developments
  • 13.11 DEAFARMA
    • 13.11.1 DEAFARMA Company Information
    • 13.11.2 DEAFARMA Latanoprost API Product Offered
    • 13.11.3 DEAFARMA Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 DEAFARMA Main Business Overview
    • 13.11.5 DEAFARMA Latest Developments
  • 13.12 Dr Pradeep Reddy’s Laboratories
    • 13.12.1 Dr Pradeep Reddy’s Laboratories Company Information
    • 13.12.2 Dr Pradeep Reddy’s Laboratories Latanoprost API Product Offered
    • 13.12.3 Dr Pradeep Reddy’s Laboratories Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Dr Pradeep Reddy’s Laboratories Main Business Overview
    • 13.12.5 Dr Pradeep Reddy’s Laboratories Latest Developments
  • 13.13 NEWCHEM
    • 13.13.1 NEWCHEM Company Information
    • 13.13.2 NEWCHEM Latanoprost API Product Offered
    • 13.13.3 NEWCHEM Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 NEWCHEM Main Business Overview
    • 13.13.5 NEWCHEM Latest Developments
  • 13.14 Chemo
    • 13.14.1 Chemo Company Information
    • 13.14.2 Chemo Latanoprost API Product Offered
    • 13.14.3 Chemo Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Chemo Main Business Overview
    • 13.14.5 Chemo Latest Developments
  • 13.15 DongWha Pharm
    • 13.15.1 DongWha Pharm Company Information
    • 13.15.2 DongWha Pharm Latanoprost API Product Offered
    • 13.15.3 DongWha Pharm Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 DongWha Pharm Main Business Overview
    • 13.15.5 DongWha Pharm Latest Developments
  • 13.16 Ausun Pharm
    • 13.16.1 Ausun Pharm Company Information
    • 13.16.2 Ausun Pharm Latanoprost API Product Offered
    • 13.16.3 Ausun Pharm Latanoprost API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 Ausun Pharm Main Business Overview
    • 13.16.5 Ausun Pharm Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Latanoprost API will have significant change from previous year. According to our (LP Information) latest study, the global Latanoprost API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Latanoprost API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Latanoprost API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Latanoprost API market, reaching US$ million by the year 2028. As for the Europe Latanoprost API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Latanoprost API players cover Sanofi, Cayman Pharma, Fleming Laboratories, and Euroapi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Latanoprost API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Liquid
Powder

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Glaucoma
High Eye Pressure
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
Cayman Pharma
Fleming Laboratories
Euroapi
Gentec Pharmaceutical Group
Century Pharmaceuticals
Summit Pharmaceuticals
Aspen Biopharma
Guangzhou Tosun Pharmaceutical
Berr Chemical
DEAFARMA
Dr Pradeep Reddy’s Laboratories
NEWCHEM
Chemo
DongWha Pharm
Ausun Pharm
Buy now